Ahn-Gook Pharmaceutical

Korean generic/branded pharma, cardiovascular/CNS focus

001540 · KOSDAQ · South Korea

Public Market Listing

001540KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for Ahn-Gook Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
2Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 3
HMG-CoA reductase / NPC1L1Small molecule
Atherosclerotic Cardiovascular Disease
Phase 3
Angiotensin II receptor / Calcium channel / Thiazide-like diureticSmall molecule
Hypertension

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (3 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$216M———report ↗
View 2 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-9M$166M$10M$31M—report ↗
2024-FY$199M$9.7M$11M—report ↗